Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Equillium (EQ) Cash & Equivalents (2022 - 2025)

Equillium (EQ) has disclosed Cash & Equivalents for 4 consecutive years, with $11.5 million as the latest value for Q2 2025.

  • On a quarterly basis, Cash & Equivalents rose 3.96% to $11.5 million in Q2 2025 year-over-year; TTM through Jun 2025 was $11.5 million, a 3.96% increase, with the full-year FY2024 number at $18.1 million, down 22.1% from a year prior.
  • Cash & Equivalents was $11.5 million for Q2 2025 at Equillium, down from $14.5 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $59.1 million in Q4 2022 to a low of $11.1 million in Q2 2024.
  • A 4-year average of $23.2 million and a median of $23.5 million in 2022 define the central range for Cash & Equivalents.
  • Biggest YoY gain for Cash & Equivalents was 33.63% in 2023; the steepest drop was 60.72% in 2023.
  • Equillium's Cash & Equivalents stood at $59.1 million in 2022, then plummeted by 60.72% to $23.2 million in 2023, then dropped by 22.1% to $18.1 million in 2024, then tumbled by 36.44% to $11.5 million in 2025.
  • Per Business Quant, the three most recent readings for EQ's Cash & Equivalents are $11.5 million (Q2 2025), $14.5 million (Q1 2025), and $18.1 million (Q4 2024).